GE HealthCare Technologies Inc. $GEHC Shares Bought by Barclays PLC

Barclays PLC grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.4% during the third quarter, Holdings Channel.com reports. The fund owned 1,753,314 shares of the company’s stock after acquiring an additional 164,821 shares during the period. Barclays PLC’s holdings in GE HealthCare Technologies were worth $131,674,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after acquiring an additional 703,903 shares during the period. Dodge & Cox lifted its stake in GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares during the last quarter. State Street Corp boosted its holdings in shares of GE HealthCare Technologies by 1.9% in the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after buying an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 2.0% during the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after purchasing an additional 231,302 shares during the last quarter. Finally, Norges Bank purchased a new stake in GE HealthCare Technologies in the second quarter valued at approximately $468,120,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on GEHC shares. The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. BTIG Research boosted their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Finally, Bank of America increased their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $74.27 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $89.77. The firm’s 50-day simple moving average is $81.81 and its 200-day simple moving average is $78.57. The firm has a market cap of $33.85 billion, a PE ratio of 16.29, a price-to-earnings-growth ratio of 1.63 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the firm earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.